Scott M. Coiante
Overview
Scott M. Coiante received an average of $1M in total compensation, including $279K in salary, at Aprea Therapeutics from 2019 to 2023.
Source: SEC filings on April 25, 2024, July 11, 2023, June 10, 2022, April 28, 2021, and April 29, 2020.
Related executives
We found five more executives who work or worked at Aprea Therapeutics.
News
Aprea Therapeutics CFO John Hamill's 2023 pay jumps 62% to $908K
April 25, 2024
Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
July 11, 2023
Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
June 10, 2022
Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
April 28, 2021
Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
April 29, 2020